» Articles » PMID: 27143047

Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma

Overview
Date 2016 May 5
PMID 27143047
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hilar cholangiocarcinomas are malignant tumors with a poor prognosis. An early prediction of prognosis for patients may help us determine treatment strategies. Aquaporin 1 is a cell membrane channel involved in water transport, cell motility, and proliferation. Increasing evidences showed that aquaporin 1 played a role in tumor prognosis and diagnosis. The purpose of this study is to evaluate the role of aquaporin 1 in hilar cholangiocarcinoma.

Methods: Here, we analyzed messenger RNA expression data of genes function as bile secretion in a data set of 169 samples using the R2 bioinformatic platform ( http://r2.amc.nl ). Quantitative polymerase chain reaction was performed to verify the gene expression in 17 hilar cholangiocarcinoma samples. Immunohistochemistry was also performed in a series of specimens from 62 hilar cholangiocarcinoma tissues, and its clinical significance was assessed by clinical correlation and Kaplan-Meier analyses.

Results: All data were analyzed using the R2 web application, aquaporin 1 was selected for further analysis. The significant expression variation of aquaporin 1 among 17 cases with cholangiocarcinoma was also found using quantitative polymerase chain reaction. The expression level of aquaporin 1 protein significantly correlated with tumor-node-metastasis stage ( P = .002) and overall survival time ( P = .010). Higher aquaporin 1 expression indicated poor prognostic outcomes ( P <.05, log-rank test). Multivariate analysis also showed strong aquaporin 1 protein expression was an independent adverse prognosticator in hilar cholangiocarcinoma ( P = .002).

Conclusion: This study highlighted the prognostic value of aquaporin 1 in hilar cholangiocarcinoma. Strong aquaporin 1 expression predicts poor survival, regardless of pathological features. Immunohistochemical detection of aquaporin 1, as a prognostic marker, may contribute to predicting clinical outcome for patients with hilar cholangiocarcinoma.

Citing Articles

Peroxiporins and Oxidative Stress: Promising Targets to Tackle Inflammation and Cancer.

da Silva I, Mlinaric M, Lourenco A, Perez-Garcia O, cipak Gasparovic A, Soveral G Int J Mol Sci. 2024; 25(15).

PMID: 39125952 PMC: 11313477. DOI: 10.3390/ijms25158381.


Loss of aquaporin-1 expression is associated with worse clinical outcomes in clear cell renal cell carcinoma: an immunohistochemical study.

Lee S, Kim B, Jung M, Moon K J Pathol Transl Med. 2023; 57(4):232-237.

PMID: 37460397 PMC: 10369134. DOI: 10.4132/jptm.2023.06.17.


YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2.

Cui Q, Wang C, Liu S, Du R, Tian S, Chen R Cell Cycle. 2021; 20(22):2413-2427.

PMID: 34709966 PMC: 8794528. DOI: 10.1080/15384101.2021.1985771.


Cell division cycle associated 5 promotes colorectal cancer progression by activating the ERK signaling pathway.

Shen A, Liu L, Chen H, Qi F, Huang Y, Lin J Oncogenesis. 2019; 8(3):19.

PMID: 30808873 PMC: 6391450. DOI: 10.1038/s41389-019-0123-5.


Role of Aquaporin 1 Signalling in Cancer Development and Progression.

Tomita Y, Dorward H, Yool A, Smith E, Townsend A, Price T Int J Mol Sci. 2017; 18(2).

PMID: 28146084 PMC: 5343835. DOI: 10.3390/ijms18020299.

References
1.
Kao S, Armstrong N, Condon B, Griggs K, McCaughan B, Maltby S . Aquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma. Cancer. 2011; 118(11):2952-61. DOI: 10.1002/cncr.26497. View

2.
Hara-Chikuma M, Verkman A . Aquaporin-1 facilitates epithelial cell migration in kidney proximal tubule. J Am Soc Nephrol. 2005; 17(1):39-45. DOI: 10.1681/ASN.2005080846. View

3.
Dong H, Cong W, Zhu Z, Wang B, Xian Z, Yu H . [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma]. Zhonghua Zhong Liu Za Zhi. 2009; 30(9):702-5. View

4.
Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S . Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996; 224(4):463-73; discussion 473-5. PMC: 1235406. DOI: 10.1097/00000658-199610000-00005. View

5.
Tannapfel A, Sommerer F, Benicke M, Weinans L, Katalinic A, Geissler F . Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. J Pathol. 2002; 197(5):624-31. DOI: 10.1002/path.1139. View